Semaglutide linked to increased risk of nonarteritic anterior ischemic optic neuropathy, but evidence remains insufficient to establish definitive conclusion.

Project Comprova, a collaborative fact-checking initiative in Brazil, has abandoned the labels “false,” “misleading,” “satire ...